Clarapath Acquires Crosscope And Combines Tissue Processing Robotics With Ai Powered Digital Pathology For Building The Lab Of The Future
Acquiring Company
Clarapath
Acquired Company
Crosscope
New YorkBiotechnologyHealthcareHealth CareMedicalMedical DeviceHealth DiagnosticsBiotechnologySoftwareHealth CareArtificial IntelligenceMachine LearningHealth DiagnosticsDescription
Clarapath, a robotics company aimed at catalyzing change in the way pathology laboratories process human and animal tissue, today announced the acquisition of Mountain View, CA-based Crosscope. Crosscope is a digital pathology company with a turnkey imaging solution providing best-in-class workflow tools and slide management along with artificial intelligence (AI) and machine learning (ML) technology to assist pathologists with better and faster decision-making.
Quick answer
Clarapath is acquiring Crosscope, announced February 27, 2023. Clarapath is based in New York, New York, United States.
- How much did Clarapath pay for Crosscope?
- The deal value was not disclosed.
- What does Clarapath do?
- Clarapath is a medical robotics company aimed at catalyzing change in the way pathology laboratories work.
- Where are Clarapath and Crosscope based?
- Clarapath is based in New York, New York, United States.
- Who are the decision-makers at Clarapath?
- Fundz holds 1 contact at Clarapath. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Rhythm Pharmaceuticals Announces Acquisition Of Xinvento B.V. And Portfolio Of Investigational Therapeutics (February 27, 2023)
- Bayer Acquires Blackford Analysis Ltd. Bolstering The Company’S Position In Digital Medical Imaging (January 18, 2023)
- Shockwave Medical Completes Acquisition Of Neovasc (April 11, 2023)
- Kymanox Acquires Eu Based Anteris Medical And Anteris Helvetia (February 2, 2023)
- Shockwave Medical Announces Agreement To Acquire Neovasc (January 17, 2023)
- Shockwave Medical To Acquire Neovasc (January 17, 2023)
Who to call at Clarapath, and when
When Clarapath changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Clarapath raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Clarapath, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Clarapath. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Clarapath makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Crosscope?
Crosscope was acquired by Clarapath, based in New York. The deal was reported on February 27, 2023. Clarapath is a medical robotics company aimed at catalyzing change in the way pathology laboratories work. Clarapath is privately held and operates in Biotechnology.
When did Clarapath acquire Crosscope?
Clarapath's acquisition of Crosscope was reported on February 27, 2023. Clarapath, a robotics company aimed at catalyzing change in the way pathology laboratories process human and animal tissue, today announced the acquisition of Mountain View, CA-based Crosscope. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Crosscope do?
Crosscope (abbreviated for "Computational Microscope") is a medical AI software company on a mission to radically transform patient care by unlocking the power of AI. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.